Civil Law And Synthetic Life Governance Claims In Thailand .

1. Introduction

Synthetic Biology Liability Litigation in Thailand concerns civil and legal disputes arising from the design, development, modification, production, testing, commercialization and environmental release of synthetic biological systems.

Synthetic biology combines genetic engineering, biotechnology, molecular biology, computational modelling and biological manufacturing to create or modify organisms, biological components and biological processes.

Examples include:

Genetically engineered microorganisms.

Synthetic DNA and genome editing.

Engineered bacteria used in industrial manufacturing.

Synthetic vaccines and biological medicines.

Gene-drive technologies.

Artificially designed biological systems.

Synthetic organisms used in agriculture.

Engineered microorganisms used for environmental remediation.

Laboratory-created biological materials.

AI-assisted genetic engineering.

In Thailand, synthetic biology can create disputes involving personal injury, environmental contamination, defective biological products, intellectual property, research negligence, contractual liability and commercial exploitation of genetic resources.

Central legal question: Who should bear civil liability when a synthetic biological product, genetically modified organism or engineered biological process causes injury to individuals, property, public health or the environment?

An important qualification is necessary: Thailand does not yet have a clearly established body of reported court decisions specifically addressing civil liability for synthetic biology. Therefore, this analysis distinguishes actual Thai judicial precedents involving relevant legal principles from comparative biotechnology and product-liability cases. The comparative cases are not binding Thai precedents.

2. Legal framework governing synthetic biology in Thailand

Thailand's synthetic biology liability framework draws upon constitutional protections, civil liability legislation, environmental regulation, public-health legislation and biotechnology-related regulatory requirements.

A. Constitution of Thailand B.E. 2560 (2017)

The Constitution establishes important principles concerning environmental protection, public health and community rights.

Relevant provisions include:

Section 25: Constitutional rights and liberties.

Section 26: Restrictions on rights must comply with constitutional requirements.

Section 43: Community rights concerning natural resources and environmental management.

Section 47: Protection of public health and access to public-health services.

Section 55: State responsibility concerning public-health services.

Section 57: State duties concerning natural resources and environmental protection.

Section 58: Environmental impact assessment and public participation for activities that may seriously affect natural resources, environmental quality, health or quality of life.

These provisions may become relevant when synthetic organisms are released into the environment or biotechnology activities create substantial risks to communities.

B. Civil and Commercial Code

The Thai Civil and Commercial Code is particularly important for private-law liability.

ProvisionRelevance to synthetic biology
Section 5Good-faith exercise of rights and performance of obligations
Section 150Invalidity of transactions contrary to law, public order or good morals
Section 213Enforcement of obligations
Section 215Damages for non-performance
Section 222Scope of contractual damages
Section 420General tort liability
Section 425Employer liability for employees' wrongful acts committed in the course of employment
Section 427Liability of principals and agents in relevant circumstances
Section 437Liability relating to certain dangerous things and vehicles

Section 420 is especially important.

A person who wilfully or negligently unlawfully injures another person's life, body, health, liberty, property or rights may be liable to compensate the injured person.

For example, if a biotechnology company negligently releases an engineered microorganism and the release causes legally recognizable damage to neighbouring agricultural land, a claim under Section 420 may arise.

C. Product Liability Act B.E. 2551 (2008)

The Liability for Damages Arising from Unsafe Products Act is especially relevant to synthetic biology commercialization.

It establishes liability mechanisms concerning unsafe products and provides protection for consumers.

Relevant principles include:

Manufacturers and other statutory responsible parties may be liable for damage caused by unsafe products.

The claimant must establish the relevant damage and connection with the product.

Statutory defenses may be available in specified circumstances.

The Act provides special evidentiary and liability protections for injured consumers.

Multiple responsible business operators may face liability under the statutory framework.

This legislation may apply to qualifying biological products, including certain vaccines, engineered medical products and biotechnology-derived consumer products.

Its application depends on whether the particular biological material qualifies as a product within the statutory definition and whether the defendant falls within the responsible categories.

D. National Environmental Quality Act B.E. 2535 (1992)

The Enhancement and Conservation of National Environmental Quality Act is relevant when synthetic organisms or biological manufacturing activities cause environmental contamination.

Important provisions include:

Section 46: Environmental impact assessment requirements.

Section 49: Environmental assessment approval procedures.

Section 96: Liability for pollution damage.

Section 97: Compensation for damage to state-owned natural resources.

Section 96 is particularly important where pollution originating from a source causes legally recognized damage to another person or property.

Section 97 provides a separate framework for compensation where protected natural resources are damaged.

E. Hazardous Substance Act B.E. 2535 (1992)

Synthetic biological products and associated chemical or biological substances may also raise regulatory questions under the Hazardous Substance Act.

Depending on their classification, intended use and characteristics, relevant substances may require:

Registration or notification.

Import authorization.

Manufacturing authorization.

Storage and handling controls.

Safety documentation.

Transportation compliance.

Disposal safeguards.

Not every genetically modified organism or synthetic biological material automatically qualifies as a hazardous substance under this legislation.

F. Plant Quarantine Act B.E. 2507 (1964) and related agricultural controls

Agricultural biotechnology may involve genetically modified plants, microorganisms and biological materials.

Relevant controls may concern:

Importation of regulated organisms.

Plant-health protection.

Prevention of agricultural contamination.

Inspection and quarantine.

Protection of agricultural production.

These laws can become relevant when synthetic biological technologies affect seeds, crops, agricultural microorganisms or plant genetic resources.

3. Main categories of synthetic biology liability

A. Genetic engineering and organism-release liability

This category concerns damage caused by genetically engineered or synthetically modified organisms.

Examples include:

Accidental release of engineered bacteria.

Contamination of conventional agricultural crops.

Uncontrolled spread of genetically modified plants.

Genetic modification of microorganisms used in agriculture.

Unexpected changes in engineered organisms.

Contamination of neighbouring farms through biological materials.

Example: A biotechnology company conducts field trials of an engineered papaya variety. The organism spreads beyond the authorized research area and contaminates neighbouring agricultural production.

Potential claims may involve:

Negligence under Section 420 of the Civil and Commercial Code.

Administrative liability for failure to supervise.

Compensation for agricultural losses.

Environmental restoration.

Regulatory enforcement.

The Thai genetically modified papaya litigation is particularly relevant to this category.

B. Laboratory negligence and research liability

Synthetic biology research requires strict laboratory procedures.

Liability may arise from:

Failure to maintain appropriate containment facilities.

Negligent storage of biological materials.

Unauthorized experimentation.

Inadequate laboratory safety procedures.

Failure to supervise laboratory personnel.

Accidental exposure of workers to biological agents.

For example, if a research institution negligently stores an engineered microorganism and an employee suffers injury, the institution may face liability under Section 420.

Section 425 may also apply where an employee commits a wrongful act in the course of employment.

C. Synthetic biological product liability

This category involves defective or unsafe products developed using synthetic biology.

Examples include:

Engineered vaccines.

Synthetic biological medicines.

Genetically engineered food products.

Engineered probiotics.

Biological diagnostic kits.

Synthetic therapeutic proteins.

A manufacturer may face liability if a qualifying unsafe product causes injury to a consumer.

Under Thailand's Product Liability Act B.E. 2551, statutory liability may apply without requiring the injured consumer to prove the manufacturer's negligence in the ordinary manner.

Potential issues include:

Manufacturing defects.

Unsafe product design.

Inadequate warnings.

Inadequate safety testing.

Undisclosed biological risks.

Failure to conduct appropriate post-market monitoring.

D. Environmental contamination litigation

Synthetic organisms may interact with ecosystems in unpredictable ways.

Environmental disputes can involve:

Contamination of agricultural soil.

Biological contamination of water resources.

Spread of engineered microorganisms.

Damage to native species.

Loss of biodiversity.

Harm to protected ecosystems.

Section 96 of the National Environmental Quality Act may become relevant when pollution from an identifiable source causes damage.

Section 97 may also apply where state-owned natural resources are damaged.

E. Genetic data and biological sample ownership

Synthetic biology frequently uses human DNA, biological samples and genetic information.

Disputes may concern:

Unauthorized collection of biological samples.

Commercial use of donated genetic material.

Ownership of research specimens.

Genetic information confidentiality.

Unauthorized sequencing.

Research commercialization without appropriate consent.

Relevant legislation includes:

National Health Act B.E. 2550, particularly Section 7.

Personal Data Protection Act B.E. 2562, particularly Section 26.

Civil and Commercial Code, Section 420.

Patent Act B.E. 2522.

Human genetic information is particularly sensitive personal data under the PDPA.

F. Intellectual property and synthetic biology ownership

Synthetic biology may produce commercially valuable inventions, including engineered genetic sequences, synthetic proteins, biological manufacturing processes and modified microorganisms.

Disputes may involve:

Patent ownership.

Employee inventions.

Research collaboration agreements.

Licensing violations.

Unauthorized commercial exploitation.

Ownership of genetically engineered plant varieties.

Thailand's Patent Act B.E. 2522 and Plant Varieties Protection Act B.E. 2542 may be relevant.

An important distinction is that naturally occurring biological material is not automatically patentable merely because it has been isolated. A claimed invention must satisfy the applicable statutory patentability requirements.

4. Important case laws and judicial precedents

The following cases provide relevant principles for synthetic biology litigation.

Research qualification: There are not six established Thai court judgments specifically deciding synthetic biology liability. To avoid inventing authorities, the following list separates Thai cases involving biotechnology, environmental and product liability from foreign comparative cases involving genetic research and biotechnology. Foreign decisions are persuasive academic comparisons only, not binding Thai precedents.

A. Thai judicial decisions

Case 1. Greenpeace Southeast Asia v. Department of Agriculture – Supreme Administrative Court Decision No. A.384/2557 (2014)

Direct Thai biotechnology precedent

Subject: Genetically modified papaya and biological contamination

This is one of the most relevant Thai judicial decisions for synthetic biology liability.

Facts:

Greenpeace challenged the Department of Agriculture's approval of open-field genetically modified papaya trials.

The organization alleged that the experiments resulted in the spread of genetically modified material beyond the authorized research area.

It also argued that the Department had failed to perform its legal duties to prevent contamination.

Legal issues:

Whether the Department had authority to approve the research.

Whether the Department had properly controlled genetically modified organisms.

Whether regulatory negligence could create legal responsibility.

Whether sufficient corrective action had been taken.

Court's reasoning:

The Supreme Administrative Court recognized the Department's authority to undertake agricultural research.

However, it also identified a failure to perform the legally required duty to control the spread and contamination of genetically modified material.

The Court considered the relevant strict-liability principle applicable to the Department's regulatory responsibility.

Nevertheless, it found that the measures subsequently taken to investigate, eliminate contamination and stop the experiments were sufficient. The Court therefore upheld the dismissal of the claim.

Legal significance:

Government agencies have responsibilities concerning biological contamination.

Approval of research does not eliminate the obligation to control its environmental consequences.

Corrective measures are relevant when courts assess administrative responsibility.

Biological contamination can raise questions of administrative and environmental liability.

Application to synthetic biology: The reasoning is relevant to engineered bacteria, synthetic microorganisms and genetically modified agricultural organisms released during research or commercial activity.

Case 2. Greenpeace GMO Papaya Litigation – Central Administrative Court Judgment No. 1045/2551 (2008)

Subject: Government supervision of genetically modified organisms

This was the earlier judicial stage of the same broader GMO papaya litigation discussed in Case 1. It should not be counted as an entirely independent dispute.

Facts:

Greenpeace challenged the Department of Agriculture's handling of genetically modified papaya experiments and alleged that inadequate controls had allowed contamination of agricultural areas.

Legal issues:

Government responsibility for supervising biotechnology research.

Compliance with environmental safeguards.

Prevention of biological contamination.

Adequacy of regulatory corrective measures.

Judicial significance:

The proceedings demonstrate that governmental authority to conduct biotechnology research must be exercised alongside statutory responsibilities for environmental and agricultural protection.

The Supreme Administrative Court subsequently upheld the dismissal in Decision No. A.384/2557.

Application: This litigation is particularly relevant to claims involving experimental synthetic organisms, biological containment and agricultural contamination.

Case 3. Map Ta Phut Environmental Litigation – Supreme Administrative Court Order No. 592/2552 (2009)

Subject: Environmental assessment and industrial biotechnology risks

The Map Ta Phut proceedings involved challenges to industrial and energy-related projects that allegedly proceeded without satisfying constitutional environmental safeguards.

Legal issues:

Environmental assessment requirements.

Health risks affecting surrounding communities.

Public participation.

Preventive judicial remedies.

Administrative compliance.

Court's reasoning:

The Supreme Administrative Court recognized the importance of constitutional environmental protections and ordered suspension of specified projects pending compliance with the relevant requirements.

Legal significance:

The decision demonstrates that projects presenting serious environmental or health risks may be subject to judicial intervention before irreversible harm occurs.

Application to synthetic biology: A large biological manufacturing facility involving engineered microorganisms may require environmental assessment where its activities fall within applicable legal requirements and may seriously affect the environment or community health.

Case 4. EGAT Mae Moh Environmental Litigation – Supreme Administrative Court Judgments Nos. A.749–764/2557 (2014)

Subject: Environmental damage, public authorities and compensation

This litigation concerned environmental problems associated with the Mae Moh coal-mining and electricity-generation complex in Lampang Province.

Residents alleged environmental harm and health-related injuries resulting from industrial operations.

Legal issues:

Compliance with environmental standards.

Public authority responsibilities.

Environmental restoration.

Causation and individual compensation.

Judicial significance:

The decisions illustrate the importance of distinguishing environmental regulatory violations from individual claims for personal injury.

Environmental restoration and compliance obligations may be considered separately from the evidence needed to establish individual compensation.

Application to synthetic biology: If a biological manufacturing facility releases engineered organisms that damage agricultural land or water resources, similar questions concerning environmental compliance, causation and restoration may arise.

Case 5. Chatree Gold Mine Environmental Class Action – Bangkok Civil Court Judgment (2025)

Subject: Toxic contamination and civil environmental liability

This is a more recent Thai environmental-liability precedent.

Facts:

Hundreds of residents brought a class action against the operator of the Chatree Gold Mine, alleging contamination involving substances including arsenic, cyanide and manganese.

They sought compensation for environmental and health-related harm.

Court's decision:

The Bangkok Civil Court found the mining operator liable and ordered compensation of approximately THB 50,000–200,000 per affected person, together with specified medical and emotional-distress compensation.

The judgment is significant because it illustrates the use of collective civil litigation for environmental damage.

AP News

 

Application to synthetic biology:

The case offers a useful comparison for situations where biological manufacturing or engineered microorganisms allegedly cause widespread contamination affecting multiple households or agricultural producers.

The underlying contamination involved mining pollutants, not synthetic organisms.

Case 6. Thai Consumer Black Case No. ผบ 1500/2558

Subject: Unsafe product liability and consumer protection

This Thai consumer proceeding is discussed in legal scholarship concerning the Liability for Damages Arising from Unsafe Products Act B.E. 2551.

The academic analysis compares the case with the American Escola decision and examines manufacturer liability and the burden of proof in unsafe-product claims.

Thai-Journal Online

 

Legal significance:

The case is relevant to understanding how Thailand's product-liability framework operates when consumers allege injury from unsafe products.

Application to synthetic biology: A consumer injured by a qualifying unsafe synthetic biological product may consider the statutory product-liability framework, subject to the Act's requirements.

The reported academic material identifies the black-case number. It should not be represented as a verified final Supreme Court precedent or as a case specifically involving biotechnology.

B. Comparative international judicial precedents

These cases are useful because Thailand's synthetic biology legislation and judicial practice have not yet developed a comprehensive set of specific synthetic biology liability decisions.

Case 7. Moore v. Regents of the University of California (1990) – United States

Subject: Ownership of human biological materials and informed consent

Facts:

John Moore provided biological samples during medical treatment. Researchers subsequently developed a commercially valuable cell line from his biological material without adequately disclosing their financial interests.

Legal issues:

Ownership of human biological materials.

Informed consent.

Research commercialization.

Fiduciary duties of medical professionals.

Decision:

The California Supreme Court rejected Moore's conversion claim concerning ownership of the excised cells but allowed certain claims involving failure to disclose conflicts of interest and breach of fiduciary duty to proceed.

Relevance to Thailand:

This case is important when synthetic biology researchers use human biological materials for commercial research without adequate disclosure or consent.

Case 8. Greenberg v. Miami Children's Hospital Research Institute (2003) – United States

Subject: Genetic research commercialization and donor rights

Facts:

Families affected by Canavan disease contributed biological samples and supported genetic research.

Researchers subsequently developed and patented a genetic testing method.

The families challenged aspects of the commercialization of the research.

Decision:

The federal court rejected important ownership-based claims while considering other claims involving informed consent, fiduciary relationships and unjust enrichment.

Relevance to Thailand:

The case highlights the importance of informed consent, research agreements and transparency concerning the commercial exploitation of genetic materials.

Case 9. Association for Molecular Pathology v. Myriad Genetics (2013) – United States Supreme Court

Subject: Synthetic DNA, genetic invention and patentability

Facts:

Myriad Genetics obtained patents involving BRCA1 and BRCA2 genes used in hereditary cancer testing.

Legal issue:

Whether naturally occurring DNA sequences could be patented merely because they had been isolated.

Decision:

The US Supreme Court held that naturally occurring DNA was not patentable merely because it had been isolated.

However, synthetically created complementary DNA (cDNA) could qualify for patent protection, subject to applicable requirements.

Relevance to Thailand:

This decision is relevant to synthetic biology patent disputes involving engineered DNA sequences, synthetic genetic constructs and biological inventions.

Case 10. Monsanto Canada Inc. v. Schmeiser (2004) – Supreme Court of Canada

Subject: Genetically modified organisms and intellectual property liability

Facts:

A Canadian farmer, Percy Schmeiser, was accused of infringing Monsanto's patent involving genetically modified canola.

The dispute concerned the presence and cultivation of patented genetically modified plants on the farmer's land.

Decision:

The Supreme Court of Canada found patent infringement because Schmeiser had deliberately cultivated and harvested the patented plants, exercising control over the patented invention.

However, the Court did not award Monsanto profits because there was no demonstrated profit attributable to the patented invention.

Relevance to Thailand:

This decision is useful for disputes involving:

Genetically engineered crops.

Patent infringement.

Unauthorized biological reproduction.

Commercial exploitation of modified organisms.

Rights of agricultural biotechnology developers.

It also demonstrates that patent infringement and environmental contamination are legally distinct questions.

5. Civil liability principles applicable to synthetic biology

A. Negligence liability

Section 420 of Thailand's Civil and Commercial Code provides the primary foundation for ordinary tort claims.

A claimant generally needs to establish:

A wrongful act.

Intentional or negligent conduct.

Legally recognized injury or damage.

A sufficient causal connection between the wrongful conduct and the damage.

Example: A synthetic biology laboratory negligently releases an engineered microorganism, resulting in contamination of neighbouring agricultural property.

The affected farmer may seek compensation for proven property damage and other legally recoverable losses.

B. Strict product liability

The Product Liability Act provides an additional route for qualifying unsafe biological products.

Unlike ordinary negligence litigation, the injured consumer does not generally have to establish the manufacturer's negligence in the same way.

Potential defendants include statutory responsible business operators such as manufacturers, importers and sellers, depending on their roles and the Act's definitions.

The Act also provides for certain additional damages, including emotional-distress compensation and punitive damages in specified circumstances.

C. Employer and institutional liability

Sections 425 and 427 of the Civil and Commercial Code may be relevant to wrongful acts committed by employees or representatives.

For example:

A laboratory employee negligently handles synthetic biological materials while performing assigned research duties.

Depending on the facts and legal relationship, the employer or principal may also face liability.

D. Environmental liability

Environmental damage may involve separate claims under:

Civil and Commercial Code Section 420.

National Environmental Quality Act Section 96.

National Environmental Quality Act Section 97.

Applicable public-health and environmental regulations.

A company may have restoration obligations in addition to its responsibility to compensate affected individuals.

E. Medical and research liability

Where synthetic biology is used in medical treatment or clinical research, liability may arise from:

Lack of informed consent.

Negligent clinical procedures.

Inadequate safety testing.

Failure to disclose material risks.

Misuse of genetic information.

Defective medical products.

The legal framework may involve tort law, product liability, medical-professional standards and personal-data protection.

6. Important regulatory and institutional responsibilities

InstitutionResponsibility
Ministry of Public HealthPublic-health and biological product regulation
Department of Medical SciencesLaboratory and medical-science oversight
Department of AgricultureAgricultural biotechnology and plant-health controls
Food and Drug AdministrationRegulation of relevant medicines, biological products and foods
Department of Industrial WorksIndustrial operations and applicable environmental controls
Office of Natural Resources and Environmental Policy and PlanningEnvironmental assessment administration
Department of Intellectual PropertyBiotechnology patents and intellectual property
Personal Data Protection CommitteePersonal-data protection oversight
Civil CourtsPrivate-law and product-liability disputes
Administrative CourtsJudicial review of unlawful administrative action

7. Important challenges in synthetic biology litigation

A. Difficulty proving causation

Synthetic biological organisms may interact with existing ecosystems.

It may be difficult to establish whether a particular organism caused:

Agricultural contamination.

Human illness.

Damage to biodiversity.

Water contamination.

Loss of commercial production.

Expert scientific evidence, laboratory records and genetic sequencing may be essential.

B. Uncertainty concerning biological ownership

Synthetic biology raises questions concerning the ownership and commercial use of:

Human genetic material.

Modified microorganisms.

Synthetic DNA.

Biological research samples.

Engineered plant varieties.

Thailand needs to balance intellectual property rights with consent, privacy, public health and biological-resource protection.

C. Cross-border liability

Synthetic biological products may be manufactured in one country, imported into Thailand and distributed across several jurisdictions.

This raises questions concerning:

Manufacturer liability.

Importer responsibility.

Applicable law.

Jurisdiction.

Enforcement of foreign judgments.

Cross-border environmental harm.

D. Regulatory gaps

Thailand is a party to the Cartagena Protocol on Biosafety.

However, academic legal research has identified shortcomings in Thailand's comprehensive regulation of living modified organisms, including the absence of a fully integrated biosafety liability framework in the research discussed.

Thai-Journal Online+1

 

Synthetic biology also raises issues that may extend beyond conventional genetically modified organisms.

A dedicated framework could clarify:

Who is legally responsible.

Which biological activities are regulated.

What constitutes biological damage.

How causation is established.

What compensation is available.

How environmental restoration is enforced.

8. Suggested legal reforms for Thailand

The following reforms could improve synthetic biology liability governance.

Proposed reformExpected legal benefit
Dedicated biosafety legislationClearer responsibilities for engineered organisms
Mandatory biological risk assessmentsBetter prevention of biological harm
Laboratory liability insuranceImproved compensation for victims
Biological containment standardsReduced accidental-release risks
Genetic data protectionStronger protection of individual privacy
Synthetic biological product monitoringBetter consumer protection
Environmental restoration requirementsAccountability for ecosystem damage
Research consent regulationsProtection of research participants
Cross-border liability cooperationBetter remedies for international harm
Public biological incident reportingGreater regulatory transparency

9. Practical examples of potential litigation

DisputePotential legal basis
Engineered bacteria contaminate farmlandSection 420 and environmental legislation
Synthetic vaccine causes injuryProduct Liability Act
Research laboratory negligently releases organismsSections 420 and 425
Genetic samples are commercialized without proper consentTort, privacy and contractual law
Engineered crops infringe protected plant or patent rightsPatent Act and Plant Varieties Protection Act
Biological manufacturing contaminates waterEnvironmental legislation and tort law
Biotechnology company breaches research agreementSections 213, 215 and 222
Government fails to supervise biological field trialsAdministrative liability and judicial review

10. Conclusion

Civil Law and Synthetic Biology Liability Litigation in Thailand represents an emerging legal field involving biotechnology, civil responsibility, intellectual property, environmental protection, consumer rights and scientific research governance.

The Thai GMO papaya litigation, particularly Supreme Administrative Court Decision No. A.384/2557, is especially important because it demonstrates that biological contamination and government supervision can create significant legal issues.

The other Thai environmental and consumer decisions provide related principles concerning compensation, causation, unsafe products and administrative responsibility.

The comparative decisions in Moore, Greenberg, Myriad Genetics and Monsanto v. Schmeiser offer further guidance concerning genetic materials, informed consent, synthetic DNA and biotechnology patents.

The central legal principles are:

Synthetic biology research must comply with applicable safety and regulatory requirements.

Negligent handling of engineered organisms may create civil liability.

Unsafe biological products may attract statutory product liability.

Environmental contamination may require compensation and restoration.

Genetic information and biological samples require appropriate legal protection.

Biotechnology patents must satisfy statutory patentability requirements.

Research institutions and commercial enterprises must respect informed consent and contractual obligations.

Government authorities may be subject to judicial scrutiny for failure to perform their statutory duties.

Overall conclusion: Thailand's civil-law framework can address many synthetic biology disputes through existing tort, product-liability, environmental, privacy and intellectual-property legislation. However, a more comprehensive biosafety liability framework would improve legal certainty, scientific accountability, environmental protection and compensation for victims.

Academic note: The cases are presented as six Thai-related judicial authorities or proceedings and four comparative foreign precedents. The GMO papaya judgments are stages of the same litigation, not separate factual disputes. The comparative cases are not binding in Thailand. This distinction is important when using the material in academic research or legal submissions.

 

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT